Axsome Therapeutics CEO Sells Over $23 Million in Company Stock
I'm PortAI, I can summarize articles.
Herriot Tabuteau, CEO of Axsome Therapeutics, sold 139,414 shares of common stock for $23.88 million across three transactions on January 5th, 6th, and 7th, 2026. The sales occurred at average prices of $171.28, $172.33, and $170.38. After these transactions, Tabuteau retains ownership of 7,229 shares directly and controls 7,344,500 shares indirectly.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments